Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
Status: Enrolling
Updated:  4/19/2011
University of Utah, Moran Eye Center
mi
from
Salt Lake City, UT
Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
Status: Enrolling
Updated: 4/19/2011
University of Utah, Moran Eye Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
Status: Enrolling
Updated:  4/19/2011
Medical College of Wisconsin--Eye Insititute
mi
from
Milwaukee, WI
Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
Status: Enrolling
Updated: 4/19/2011
Medical College of Wisconsin--Eye Insititute
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
A Prospective Single Institution Study of Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
Status: Enrolling
Updated:  4/21/2011
Allegheny General Neurology Department/Neuro-Oncology
mi
from
Pittsburgh, PA
Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
A Prospective Single Institution Study of Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
Status: Enrolling
Updated: 4/21/2011
Allegheny General Neurology Department/Neuro-Oncology
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Brimonidine Therapy
Study of Safety and IOP Lowering Efficacy of Transdermal Brimonidine Therapy
Status: Enrolling
Updated:  4/28/2011
Eye Surgical and Medical Associates
mi
from
Visalia, CA
Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Brimonidine Therapy
Study of Safety and IOP Lowering Efficacy of Transdermal Brimonidine Therapy
Status: Enrolling
Updated: 4/28/2011
Eye Surgical and Medical Associates
mi
from
Visalia, CA
Click here to add this to my saved trials
Does LMA Instead of ET Tube Affect Incidence of Postoperative Vomiting in Children Undergoing Strabismus Correction?
Does Using Laryngeal Mask Airway (LMA) Instead of an Endotracheal Tube (ET Tube) Affect the Incidence of Postoperative Vomiting in Children Undergoing Strabismus Correction? - An Observational Study
Status: Enrolling
Updated:  5/3/2011
Memorial Hermann Hospital
mi
from
Houston, TX
Does LMA Instead of ET Tube Affect Incidence of Postoperative Vomiting in Children Undergoing Strabismus Correction?
Does Using Laryngeal Mask Airway (LMA) Instead of an Endotracheal Tube (ET Tube) Affect the Incidence of Postoperative Vomiting in Children Undergoing Strabismus Correction? - An Observational Study
Status: Enrolling
Updated: 5/3/2011
Memorial Hermann Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Ranibizumab for Neovascularization in Sickle Cell Retinopathy
A Phase I Study to Evaluate the Ocular and Non Ocular Safety of Ranibizumab in Treating Neovascularization Secondary to Sickle Cell Retinopathy
Status: Enrolling
Updated:  6/21/2011
Kresge Eye Institute
mi
from
Detroit, MI
Ranibizumab for Neovascularization in Sickle Cell Retinopathy
A Phase I Study to Evaluate the Ocular and Non Ocular Safety of Ranibizumab in Treating Neovascularization Secondary to Sickle Cell Retinopathy
Status: Enrolling
Updated: 6/21/2011
Kresge Eye Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia [HD-LIPT]
Status: Enrolling
Updated:  6/23/2011
Eye Center of Northern Colorado
mi
from
Fort Collins, CO
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia [HD-LIPT]
Status: Enrolling
Updated: 6/23/2011
Eye Center of Northern Colorado
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Progression of Diabetic Retinopathy Post Bariatric Surgery (BS)
The Effect of Bariatric Surgery on the Progression of Diabetic Retinopathy
Status: Enrolling
Updated:  7/12/2011
NYU SOM
mi
from
New York, NY
Progression of Diabetic Retinopathy Post Bariatric Surgery (BS)
The Effect of Bariatric Surgery on the Progression of Diabetic Retinopathy
Status: Enrolling
Updated: 7/12/2011
NYU SOM
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab.
Status: Enrolling
Updated:  7/25/2011
California Retina Consultants
mi
from
Bakersfield, CA
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab.
Status: Enrolling
Updated: 7/25/2011
California Retina Consultants
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab.
Status: Enrolling
Updated:  7/25/2011
Shiley Eye Center - UCSD
mi
from
La Jolla, CA
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab.
Status: Enrolling
Updated: 7/25/2011
Shiley Eye Center - UCSD
mi
from
La Jolla, CA
Click here to add this to my saved trials
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab.
Status: Enrolling
Updated:  7/25/2011
California Retina Consultants
mi
from
Santa Barbara, CA
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab.
Status: Enrolling
Updated: 7/25/2011
California Retina Consultants
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab.
Status: Enrolling
Updated:  7/25/2011
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab.
Status: Enrolling
Updated: 7/25/2011
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evoked Retinal Response
Evoked Visual Response Using Pulsed Ultrasound
Status: Enrolling
Updated:  8/10/2011
Columbia University Medical Center
mi
from
New York, NY
Evoked Retinal Response
Evoked Visual Response Using Pulsed Ultrasound
Status: Enrolling
Updated: 8/10/2011
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy
Phase 2 Study of Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy
Status: Enrolling
Updated:  8/29/2011
Eye Surgical and Medical Associates
mi
from
Visalia, CA
Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy
Phase 2 Study of Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy
Status: Enrolling
Updated: 8/29/2011
Eye Surgical and Medical Associates
mi
from
Visalia, CA
Click here to add this to my saved trials
A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
A Phase I/II Multi-Center, Randomized, Double-Masked, Placebo-Controlled, Dose-Escalation Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics (Efficacy) of Chronic Twice-Daily Topical Monocular Application of INO-8875 Ophthalmic Formulation in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
Status: Enrolling
Updated:  8/30/2011
Lugene Eye Institute
mi
from
Glendale, CA
A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
A Phase I/II Multi-Center, Randomized, Double-Masked, Placebo-Controlled, Dose-Escalation Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics (Efficacy) of Chronic Twice-Daily Topical Monocular Application of INO-8875 Ophthalmic Formulation in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 8/30/2011
Lugene Eye Institute
mi
from
Glendale, CA
Click here to add this to my saved trials
Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration
Resolution of Vitreomacular Adhesion (VMA) Associated With Neovascular Age Related Macular Degeneration (AMD) With Intravitreal Microplasmin
Status: Enrolling
Updated:  9/26/2011
Jules Stein Eye Institute, UCLA
mi
from
Los Angeles, CA
Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration
Resolution of Vitreomacular Adhesion (VMA) Associated With Neovascular Age Related Macular Degeneration (AMD) With Intravitreal Microplasmin
Status: Enrolling
Updated: 9/26/2011
Jules Stein Eye Institute, UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery
Phase IV Study: A Prospective Two-Site Study to Evaluate the Safety and Tolerance of Besivance Versus Vigamox Prophylactically Pre and Post Operatively in Subjects Undergoing Routine Cataract Surgery
Status: Enrolling
Updated:  10/18/2011
Ophthalmology Associates
mi
from
St. Louis, MO
2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery
Phase IV Study: A Prospective Two-Site Study to Evaluate the Safety and Tolerance of Besivance Versus Vigamox Prophylactically Pre and Post Operatively in Subjects Undergoing Routine Cataract Surgery
Status: Enrolling
Updated: 10/18/2011
Ophthalmology Associates
mi
from
St. Louis, MO
Click here to add this to my saved trials
2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery
Phase IV Study: A Prospective Two-Site Study to Evaluate the Safety and Tolerance of Besivance Versus Vigamox Prophylactically Pre and Post Operatively in Subjects Undergoing Routine Cataract Surgery
Status: Enrolling
Updated:  10/18/2011
Ophthalmology Consultants, Ltd.
mi
from
St. Louis, MO
2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery
Phase IV Study: A Prospective Two-Site Study to Evaluate the Safety and Tolerance of Besivance Versus Vigamox Prophylactically Pre and Post Operatively in Subjects Undergoing Routine Cataract Surgery
Status: Enrolling
Updated: 10/18/2011
Ophthalmology Consultants, Ltd.
mi
from
St. Louis, MO
Click here to add this to my saved trials
REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study
REVOLUTIONARY: REtinal Vein OccLUsion Treatment With Scatter Laser Guided by Ultra Widefield angIOgraphy in combiNAtion With Ranibizumab Study Phase II
Status: Enrolling
Updated:  11/1/2011
Retina Associates of Florida, P.A.
mi
from
Tampa, FL
REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study
REVOLUTIONARY: REtinal Vein OccLUsion Treatment With Scatter Laser Guided by Ultra Widefield angIOgraphy in combiNAtion With Ranibizumab Study Phase II
Status: Enrolling
Updated: 11/1/2011
Retina Associates of Florida, P.A.
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Sall Research Medical Center, Inc.
mi
from
Artesia, CA
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Sall Research Medical Center, Inc.
mi
from
Artesia, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
USC Department of Ophthalmology
mi
from
Los Angeles, CA
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
USC Department of Ophthalmology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Wolstan Eye Associates
mi
from
Torrance, CA
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Wolstan Eye Associates
mi
from
Torrance, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
East Florida Eye Institute
mi
from
Stuart, FL
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
East Florida Eye Institute
mi
from
Stuart, FL
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Seidenberg Protzko Eye Associates
mi
from
Bel Air, MD
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Seidenberg Protzko Eye Associates
mi
from
Bel Air, MD
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Rochester Ophthalmological Group
mi
from
Rochester, NY
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Rochester Ophthalmological Group
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Cornerstone Eye Care
mi
from
High Point, NC
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Cornerstone Eye Care
mi
from
High Point, NC
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Associated Glaucoma Consultants
mi
from
Philadelphia, PA
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Associated Glaucoma Consultants
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Keystone Research Ltd.
mi
from
Austin, TX
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Keystone Research Ltd.
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
David Shulman, MD P-A
mi
from
San Antonio, TX
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
David Shulman, MD P-A
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Eye Clinics of South Texas
mi
from
San Antonio, TX
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Eye Clinics of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Virginia Eye Consultants
mi
from
Norfolk, VA
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Virginia Eye Consultants
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
Artesia, CA
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
Artesia, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
Pasadena, CA
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
Pasadena, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
San Francisco, CA
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
Honolulu, HI
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
Kailua, HI
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
Kailua, HI
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
New York, NY
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
Inglewood, CA
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
Inglewood, CA
Click here to add this to my saved trials
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
Torrance, CA
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  11/1/2011
Research Site
mi
from
Bloomfield, CT
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 11/1/2011
Research Site
mi
from
Bloomfield, CT
Click here to add this to my saved trials
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
Indianapolis, IN
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
New Albany, IN
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
New Albany, IN
Click here to add this to my saved trials
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  11/1/2011
mi
from
Gretna, LA
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 11/1/2011
mi
from
Gretna, LA
Click here to add this to my saved trials
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
Bangor, ME
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
Bangor, ME
Click here to add this to my saved trials
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
Cleveland, OH
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
Philadelphia, PA
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
San Antonio, TX
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of Sub-tenon Ranibizumab for Recurrent Pterygia
The Use of Ranibizumab to Control Pterygium Growth in Recurrences and in Non-surgical Primary Lesions.
Status: Enrolling
Updated:  11/9/2011
University of New Mexico Health Science Center
mi
from
Albuquerque, NM
Efficacy and Safety of Sub-tenon Ranibizumab for Recurrent Pterygia
The Use of Ranibizumab to Control Pterygium Growth in Recurrences and in Non-surgical Primary Lesions.
Status: Enrolling
Updated: 11/9/2011
University of New Mexico Health Science Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials